Literature DB >> 15813502

Differential gene expression in liposarcoma, lipoma, and adipose tissue.

Keith M Skubitz1, Edward Y Cheng, Denis R Clohisy, Roby C Thompson, Amy P N Skubitz.   

Abstract

Malignant transformation is thought to be associated with changes in the expression of a number of genes, and this alteration in gene expression is felt to be critical to the development of the malignant phenotype. Sarcomas represent a diverse group of tumors derived from cells of mesenchymal origin. Marked heterogeneity exists in the biological behavior of sarcomas, even within histologic subtypes of sarcomas. In an effort to better understand the biology of liposarcomas, gene expression in normal adipose tissue, lipomas, and liposarcomas was examined using the Affymetrix microarray technology. Differences in gene expression were quantified as the fold change in gene expression among the sample sets. Differences in gene expression among normal adipose tissue, lipomas, and liposarcomas were observed. In addition, genes expressed uniquely in liposarcoma among these and 18 other tissue sample sets were identified. Gene sets were devised that allowed the separation of liposarcomas from other samples, and most normal adipose tissue from most lipomas using the Eisen clustering software "Cluster." We conclude that differences in gene expression can be identified among different tumors derived from the adipocyte series. Such differences in gene expression may help differentiate among subtypes of sarcomas, and may also yield clues to the pathophysiology of this heterogeneous group of tumors.

Entities:  

Mesh:

Year:  2005        PMID: 15813502     DOI: 10.1081/cnv-50432

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  14 in total

1.  Expression of cancer-testis antigens MAGEA1, MAGEA3, ACRBP, PRAME, SSX2, and CTAG2 in myxoid and round cell liposarcoma.

Authors:  Jessica A Hemminger; Amanda Ewart Toland; Thomas J Scharschmidt; Joel L Mayerson; Denis C Guttridge; O Hans Iwenofu
Journal:  Mod Pathol       Date:  2014-01-24       Impact factor: 7.842

2.  Paratesticular liposarcoma and contralateral angiolipoma in a 60-year-old patient.

Authors:  Michelle Christodoulidou; Pramit Khetrapal; Lilian Edmunds; Asif Muneer
Journal:  BMJ Case Rep       Date:  2015-10-05

Review 3.  Liposarcoma: a soft tissue tumor with many presentations.

Authors:  H J Mankin; K P Mankin; D C Harmon
Journal:  Musculoskelet Surg       Date:  2014-07-22

4.  NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma.

Authors:  Seth M Pollack; Achim A Jungbluth; Benjamin L Hoch; Erik A Farrar; Marie Bleakley; David J Schneider; Elizabeth T Loggers; Eve Rodler; Janet F Eary; Ernest U Conrad; Robin L Jones; Cassian Yee
Journal:  Cancer       Date:  2012-02-22       Impact factor: 6.860

5.  Malignant fibrous histiocytoma--pleomorphic sarcoma, NOS gene expression, histology, and clinical course. A pilot study.

Authors:  Adrien Daigeler; Daigeler Adrien; Ludger Klein-Hitpass; Klein-Hitpass Ludger; Ingo Stricker; Stricker Ingo; Oliver Müller; Müller Oliver; Cornelius Kuhnen; Kuhnen Cornelius; Ansgar Michael Chromik; Chromik Ansgar Michael; Lars Steinstraesser; Steinstraesser Lars; Ole Goertz; Goertz Ole; Hans-Ulrich Steinau; Steinau Hans-Ulrich; Marcus Lehnhardt; Lehnhardt Marcus
Journal:  Langenbecks Arch Surg       Date:  2009-01-22       Impact factor: 3.445

6.  Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.

Authors:  Princy Francis; Heidi Maria Namløs; Christoph Müller; Patrik Edén; Josefin Fernebro; Jeanne-Marie Berner; Bodil Bjerkehagen; Måns Akerman; Pär-Ola Bendahl; Anna Isinger; Anders Rydholm; Ola Myklebost; Mef Nilbert
Journal:  BMC Genomics       Date:  2007-03-14       Impact factor: 3.969

7.  [Dorsal liposarcoma: a rare clinical presentation].

Authors:  Odry Agbessi; Adil Arrob; Kamal Fiqhi; Lahcen Khalfi; Mohammed Nassih; Karim El Khatib
Journal:  Pan Afr Med J       Date:  2015-02-24

8.  Heterogeneous in vitro effects of doxorubicin on gene expression in primary human liposarcoma cultures.

Authors:  Adrien Daigeler; Ludger Klein-Hitpass; Michael Ansgar Chromik; Oliver Müller; Jörg Hauser; Heinz-Herbert Homann; Hans-Ulrich Steinau; Marcus Lehnhardt
Journal:  BMC Cancer       Date:  2008-10-29       Impact factor: 4.430

9.  Identification of heterogeneity among soft tissue sarcomas by gene expression profiles from different tumors.

Authors:  Keith M Skubitz; Stefan Pambuccian; J Carlos Manivel; Amy P N Skubitz
Journal:  J Transl Med       Date:  2008-05-06       Impact factor: 5.531

10.  Persistence of CD34 Stem Marker in Human Lipoma: Searching for Cancer Stem Cells.

Authors:  Barbara Zavan; Francesco De Francesco; Francesco D'Andrea; Letizia Ferroni; Chiara Gardin; Rosa Salzillo; Gianfranco Nicoletti; Giuseppe A Ferraro
Journal:  Int J Biol Sci       Date:  2015-07-18       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.